Cartalax
Cartalax is a synthetic peptide bioregulator developed by Russian scientist Vladimir Khavinson, part of a family of short peptides marketed for tissue-specific "regulation" and anti-aging purposes. Key points: What it is: A synthetic tetrapeptide (Ala-Glu-Asp-Gly / AEDG) designed to mimic naturally occurring regulatory peptides in cartilage tissue Main interest: Marketed specifically for cartilage and joint health — theorized to support chondrocyte (cartilage cell) function and slow cartilage degeneration Proposed mechanism: Based on Khavinson's "peptide bioregulator" theory — short peptides are claimed to help regulate gene expression and protein synthesis in specific tissue types (in this case, cartilage), though the mechanism isn't well validated by mainstream Western science Popular uses: Explored (mostly in Russian research) for osteoarthritis, joint degeneration, and general cartilage support/anti-aging Research status: Studies are almost entirely from Russian research groups (often linked to Khavinson's own institute)





